Related Experiment Video
Updated: Aug 9, 2026
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate
Armand Abergel1, Vincent Sapin, Nicolas Dif
1Unité des Maladies Métaboliques et Micro-nutriments, Equipe Vitamines, INRA de Clermont-Fd-Theix, 63122 Saint-Genès, Champanelle, France. aabergel@chu-clermontferrand.fr
Digestive Diseases and Sciences
|April 28, 2006
Summary
Palmitic acid, alone or with retinol, can deactivate activated hepatic stellate cells (HSC). This treatment reduces cell growth and key markers of liver fibrosis, suggesting a therapeutic potential.
Area of Science:
- Hepatology
- Cell Biology
- Biochemistry
Background:
- Liver fibrosis involves hepatic stellate cell (HSC) activation, marked by increased alpha-smooth muscle actin (alpha-SMA), proliferation, and extracellular matrix secretion.
- Trans-resveratrol is known to deactivate myofibroblast-like HSCs.
Purpose of the Study:
- To investigate the role of retinol and palmitic acid in the deactivation of activated HSCs.
- To evaluate the effects of palmitic acid and retinol on HSC proliferation and fibrotic marker expression.
Main Methods:
- Utilized a PAV-1 HSC cell line.
- Employed mass spectrometry, metabolic assays, Western blot, and immunocytochemistry.
- Treated cells with palmitic acid (75 µM) alone and in combination with retinol (2 µM).
Main Results:
- Palmitic acid, with or without retinol, significantly reduced cell proliferation and alpha-SMA expression.
- The combination of palmitic acid and retinol markedly decreased collagen type I expression.
- HSC deactivation was observed with these treatments.
Conclusions:
- Palmitic acid, alone or combined with retinol, shows potential for inducing HSC deactivation.
- These findings suggest a possible therapeutic strategy for liver fibrosis by targeting HSC activation.
